This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
Precision medicine for patients with co-existent ovarian and endometrial cancer: the COMPARE trial
Metabolic Gene-Edited CAR-T Cells For Ovarian Cancer Treatment
Metabolic engineering of CAR-T cells to overcome immune suppression
Remodeling the immune microenvironment of ovarian cancer using oncolytic viruses
Understanding how glycosylated antitumour ether lipids (GAELs) kill chemotherapy-resistant cancer cells
Investigating the “surfaceome” to discover new treatments for rare ovarian cancers
Understanding and targeting single-stranded DNA gap-filling mechanisms to improve chemotherapy response
Exploring a new therapeutic approach for rare ovarian cancers
Clonal hematopoiesis as a biomarker of poor prognosis in high-grade serous ovarian cancer
Implementation of patient-oriented Folate Receptor Alpha reporting
